India's drug makers like to call themselves the world's pharmacy. Some 10,000 factories there produce nearly $50 billion worth of drugs a year. They account for 20% of the world's generic drug supply by value. Tom Easton is our South Asia business correspondent.
Iran’s protests may have gone quiet for the moment, but that does not mean they’ve been defeated. Beneath a calmer surface, Iranians are seething and biding their time. India’s pharma sector is huge, but has long been dogged by concerns about quality control. And we reveal last year’s most newsworthy subject.
For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer